Clinical and experimental features of MuSK antibody positive MG in Japan

European Journal of Neurology

Volumn 14, Issue 9, 2007, Pages 1029-1034

  Ohta, K ^a   Shigemoto, K ^b   Fujinami, A ^c   Maruyama, N ^d   Konishi, T ^a   Ohta, M ^a,c  

^a UTANO NATIONAL HOSPITAL   (Japan)

^b EHIME UNIVERSITY   (Japan)

^c KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Clinical features; Domain; IgG subclass; Muscle specific tyrosine kinase; MuSK antibody; Myasthenia gravis; Seronegative myasthenia gravis

Indexed keywords

IMMUNOGLOBULIN G; MUSCLE SPECIFIC TYROSINE KINASE ANTIBODY; PROTEIN TYROSINE KINASE; STEROID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; JAPAN; LIMB WEAKNESS; MALE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NUCLEOTIDE SEQUENCE; PLASMAPHERESIS; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; STEROID THERAPY; THYMECTOMY;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIBODIES; EPITOPE MAPPING; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RADIOIMMUNOASSAY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC;

EID: 34548134917     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.01870.x     Document Type: Article

References (28)

1. Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nature Medicine 2001 7 : 365 368.
2. Vincent A, Bowen J, Newsom-Davis J, McConville J. Seronegative generalized myasthenia gravis: clinical features, antibodies, and their targets. Lancet Neurology 2003 2 : 99 106.
3. Evoli A, Tonali PA, Padua L, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003 126 : 2304 2311.
4. Sanders DB, EI-Salem K, Massey, JM, McConville J, Vincent A. Clinical aspects of MuSK antibody positive-seronegative MG. Neurology 2003 60 : 1978 1980.
5. McConville J, Farrugia ME, Beeson D, et al. Detection and characterization of MuSK antibodies in seronegative Myasthenia gravis. Annals of Neurology 2004 55 : 580 584.
6. Zhou L, McConville J, Chaudhry V, et al. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and - negative myasthenic patients. Muscle and Nerve 2004 30 : 55 60.
7. Padua L, Tonali P, Aprile I, et al. Seronegative myasthenia gravis: comparison of neurophysiological picture in MuSK+ and MuSK- patients. European Journal of Neurology 2006 13 : 273 276.
8. Ohta K, Shigemoto K, Kubo S, et al. MuSK Ab described in seropositive MG sera found to be Ab to alkaline phosphatase. Neurology 2005 65 : 1988.
9. Shiraishi H, Yoshimura T, Fukudome T, et al. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Annals of Neurology 2005 57 : 289 293.
10. Lee JY, Sung JJ, Cho JY, et al. MuSK antibody-positive, seronegative myasthenia gravis in Korea. Journal of Clinical Neuroscience 2006 13 : 353 355.
11. Yeh JH, Chen WH, Chiu HC, Vincent A. Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese. Neurology 2004 62 : 2131.
12. Chiu HC, de Lange GG, Willcox N, et al. Immunoglobulin allotypes in Caucasian and Chinese myasthenia gravis: differences from Japanese patients. Journal of Neurology, Neurosurgery, and Psychiatry 1988 51 : 214 217.
13. Shigemoto K, Kubo S, Maruyama N, et al. Induction of myasthenia by immunization against muscle-specific kinase. Journal of Clinical Investigation 2006 116 : 1016 1024.
14. Hopf C, Hoch W. Tyrosine phosphorylation of the muscle-specific kinase is exclusively induced by acetylcholine receptor-aggregation agrin fragments. European Journal of Biochemistry 1998 253 : 382 389.
15. Hunter WM, Greenwood FC. Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 1962 194 : 495 496.
16. Jaretzki A, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 2000 55 : 16 23.
17. Lavrnic D, Losen M, Vujic A, et al. The features of myasthenia gravis with autoantibodies to MuSK. Journal of Neurology, Neurosurgery, and Psychiatry 2005 76 : 1099 1102.
18. Diaz-Manera JA, Juarez C. Rojas-Garcia R, et al. Seronegative myasthenia gravis and antiMuSK positive antibodies: description of Spanish series. Medicina Clinica (Barc) 2005 125 : 100 102.
19. Lauriola L, Ranelletti F, Maggiano N, et al. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology 2005 64 : 536 538.
20. Leite MI, Strobel P, Jones M, et al. Fewer thymic changes in MuSK antibody-positive than in Musk antibody-negative MG. Annals of Neurology 2005 57 : 444 448.
21. Bartoccioni E, Scuderi F, Minicuci GM, et al. Anti-Musk antibodies: correlation with myasthenia gravis severity. Neurology 2006 67 : 505 507.
22. Selcen D, Fukuda T, Shen XM, Engel AG. Are MuSK antibodies the primary cause of myasthenic symptoms? Neurology 2004 62 : 1945 1950.
23. Jha S, Xu K, Maruta T, et al. Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK). Journal of Neuroimmunology 2006 175 : 107 117.
24. Vincent A, Leite MI. Neuromuscular junction autoimmune disease: muscle-specific kinase antibodies and treatments for myasthenia gravis. Current Opinion in Neurology 2005 18 : 519 525.
25. Vincent A, Bowen J, Newsom-Davis J, McConville J. Seronegative generalized myasthenia gravis: clinical features and their targets. Lancet Neurology 2003 2 : 99 106.
26. Farrugia ME, Bonifati DM, Clover L, Cossins J, Beeson D, Vincent A. Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures. Journal of Neuroimmunology, 2007 185 : 136 144.
27. Farrugia ME, Robson MD, Clover L, et al. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain 2006 129 : 1481 1492.
28. Benveniste O, Jacobson L, Farrugia ME, Clover L, Vincent A. MuSK antibody-positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo. Journal of Neuroimmunology 2005 170 : 41 48.